
|Videos|September 16, 2016
How High Cost Oncology Drugs Are Changing Specialty Pharmacy
Author(s)Lauren Santye, Assistant Editor
Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses the impact of oncology medications and how specialty pharmacies can adjust.
Advertisement
Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses the impact of oncology medications and how specialty pharmacies can adjust.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Common Virus May Hold New Clues to Lupus
2
Managing Safety and Supportive Care With Pluvicto: Insights From the PSMAddition Trial
3
FDA Approves Poherdy, First Biosimilar to Perjeta, For HER2 Breast Cancer Indications
4
Study Finds Similar Outcomes Between hMPV and RSV Hospitalizations
5

















































































































































































































